GGrantIndex
← Leaderboards

Kevin James Downes

Children'S Hosp Of Philadelphia

$5,128,443
Attributed
$7,258,847
Total exposure
5
Grants
4
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.9M · FY201825
$2M$1.5M$1M$500K$0
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$7,258,847 · 5

By mechanism

R01$5,992,592 · 2
K23$746,790 · 1
R34$308,000 · 1
T32$211,465 · 1

Top collaborators

Most similar at Children'S Hosp Of Philadelphia

Same institution · by research overlap

Others in their field

Other Emerging Leaders on “Childhood

Research focus

ChildhoodDoseBloodDrug KineticsAntibioticsChildInfectionMortalityPharmacokinetic ModelCritically Ill ChildrenSamplingRisk FactorsAntibiotic TherapyPediatric Intensive Care UnitsClinical TrialsFutureToxic EffectDrug MonitoringBiological MarkersEnrollmentProspective StudiesModels And SimulationRenal FunctionVancomycin

Grant awards (15)

Assessment of MODS and Personalized Exposures of Antibiotics$674,259
R01 · FY2025 · HD · contact PI
PediatRic sEpsiS induCed MODS: Relationship of Immune-phenotypes and antiBiotic Exposures (PRESCRIBE) study$669,906
R01 · FY2025 · HD · contact PI
Clinical Pharmacology Training Program$211,465
T32 · FY2025 · HD
PediatRic sEpsiS induCed MODS: Relationship of Immune-phenotypes and antiBiotic Exposures (PRESCRIBE) study$783,342
R01 · FY2024 · HD · contact PI
Assessment of MODS and Personalized Exposures of Antibiotics$707,539
R01 · FY2024 · HD · contact PI
PediatRic sEpsiS induCed MODS: Relationship of Immune-phenotypes and antiBiotic Exposures (PRESCRIBE) study$868,490
R01 · FY2023 · HD · contact PI
Assessment of MODS and Personalized Exposures of Antibiotics$742,800
R01 · FY2023 · HD · contact PI
Phase 1 trial of inhaled tobramycin in very preterm infants with bronchopulmonary dysplasia$308,000
R34 · FY2023 · HL · contact PI
Assessment of MODS and Personalized Exposures of Antibiotics$744,885
R01 · FY2022 · HD · contact PI
Optimizing Vancomycin Therapy in Children$149,358
K23 · FY2022 · HD · contact PI
Assessment of MODS and Personalized Exposures of Antibiotics$801,371
R01 · FY2021 · HD · contact PI
Optimizing Vancomycin Therapy in Children$149,358
K23 · FY2021 · HD · contact PI
Optimizing Vancomycin Therapy in Children$149,358
K23 · FY2020 · HD · contact PI
Optimizing Vancomycin Therapy in Children$149,358
K23 · FY2019 · HD · contact PI
Optimizing Vancomycin Therapy in Children$149,358
K23 · FY2018 · HD · contact PI